ABVC BIOPHARMA, INC. financial data

Symbol
ABVC on Nasdaq
Location
Fremont, CA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 03 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 39% % 16%
Debt-to-equity 79% % -81%
Return On Equity -70% % 82%
Return On Assets -43% % 31%
Operating Margin -923% % 79%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 25,440,407 shares 61%
Common Stock, Shares, Outstanding 25,053,193 shares 81%
Entity Public Float $37,000,000 USD 414%
Common Stock, Value, Issued $25,053 USD 81%
Weighted Average Number of Shares Outstanding, Basic 20,108,944 shares 72%
Weighted Average Number of Shares Outstanding, Diluted 20,108,944 shares 72%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $795,950 USD 104%
Cost of Revenue $763 USD -100%
Research and Development Expense $121,085 USD -32%
Operating Income (Loss) $7,151,259 USD -52%
Nonoperating Income (Expense) $1,201,546 USD -81%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $8,352,805 USD -56%
Income Tax Expense (Benefit) $527 USD 48%
Net Income (Loss) Attributable to Parent $7,908,554 USD -61%
Earnings Per Share, Basic -0.39 USD/shares 7.1%
Earnings Per Share, Diluted -0.39 USD/shares 7.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $681,480 USD 174%
Accounts Receivable, after Allowance for Credit Loss, Current $1,529 USD -0.06%
Inventory, Net $11,460 USD
Assets, Current $2,501,343 USD 15%
Property, Plant and Equipment, Net $12,835,409 USD 2411%
Operating Lease, Right-of-Use Asset $1,913,278 USD 199%
Other Assets, Noncurrent $116,966 USD -12%
Assets $21,062,203 USD 179%
Employee-related Liabilities, Current $86,744 USD -31%
Contract with Customer, Liability, Current $12,600 USD -84%
Liabilities, Current $6,163,976 USD -6%
Contract with Customer, Liability, Noncurrent $296,000 USD
Operating Lease, Liability, Noncurrent $1,600,747 USD 576%
Liabilities $7,764,723 USD 14%
Accumulated Other Comprehensive Income (Loss), Net of Tax $487,602 USD 9.4%
Retained Earnings (Accumulated Deficit) $76,858,361 USD -11%
Stockholders' Equity Attributable to Parent $11,111,861 USD 806%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $13,297,480 USD 1737%
Liabilities and Equity $21,062,203 USD 179%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $539,833 USD 44%
Net Cash Provided by (Used in) Financing Activities $428,756 USD -54%
Common Stock, Shares Authorized 100,000,000 shares 0%
Common Stock, Shares, Issued 25,053,193 shares 81%
Common Stock, Par or Stated Value Per Share 0.001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $104,247 USD -80%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1,326,985 USD 54%
Interest Paid, Excluding Capitalized Interest, Operating Activities $5,231 USD -8.2%
Deferred Tax Assets, Valuation Allowance $7,356,615 USD 15%
Deferred Tax Assets, Gross $7,356,615 USD 15%
Operating Lease, Liability $1,918,304 USD 200%
Depreciation $25,330 USD -21%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $7,866,617 USD -58%
Lessee, Operating Lease, Liability, to be Paid $2,285,283 USD 248%
Property, Plant and Equipment, Gross $16,215,506 USD 321%
Operating Lease, Liability, Current $317,557 USD -21%
Lessee, Operating Lease, Liability, to be Paid, Year Two $442,890 USD 325%
Lessee, Operating Lease, Liability, to be Paid, Year One $441,029 USD 7.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.0711 pure 497%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $366,979 USD 2284%
Lessee, Operating Lease, Liability, to be Paid, Year Three $447,886 USD 847%
Deferred Tax Assets, Operating Loss Carryforwards $6,473,705 USD 14%
Preferred Stock, Shares Authorized 20,000,000 shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four $459,843 USD 872%
Operating Lease, Payments $117,166 USD 19%
Additional Paid in Capital $96,008,258 USD 22%
Share-based Payment Arrangement, Expense $1,995,049 USD 272%
Interest Expense $1,438,684 USD 333%
Preferred Stock, Par or Stated Value Per Share 0.001 USD/shares 0%